The biology of APOL1 with insights into the association between APOL1 variants and chronic kidney disease

被引：11
|
作者：
Madhavan, Sethu M. [1 ]
O'Toole, John F. [1 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Dept Internal Med, MetroHlth Med Syst,Div Nephrol, Cleveland, OH 44109 USA
来源：
CLINICAL AND EXPERIMENTAL NEPHROLOGY | 2014年 / 18卷 / 02期
关键词：
Genetics; Apolipoprotein; HDL; APOL1; Kidney; Focal segmental glomerulosclerosis; HIV; HIV-associated nephropathy; Hypertensive nephrosclerosis; Chronic kidney disease; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; APOLIPOPROTEIN-L GENE; AFRICAN-AMERICANS; PLASMA TRIGLYCERIDES; ALLOGRAFT SURVIVAL; L-I; MYH9; TISSUE; HDL;
D O I：
10.1007/s10157-013-0907-4
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Recent studies have identified genetic variants in APOL1 that may contribute to the increased incidence of kidney disease in populations with African ancestry. Here, we review the biology of APOL1 present in the circulation and localized to the kidney as it may contribute to the pathogenesis of APOL1-associated kidney disease.
引用
收藏
页码：238 / 242
页数：5
相关论文
共 50 条
  • [1] The biology of APOL1 with insights into the association between APOL1 variants and chronic kidney disease
    Sethu M. Madhavan
    John F. O’Toole
    Clinical and Experimental Nephrology, 2014, 18 : 238 - 242
  • [2] Kidney disease and APOL1
    Yusuf, Aminu Abba
    Govender, Melanie A.
    Brandenburg, Jean-Tristan
    Winkler, Cheryl A.
    HUMAN MOLECULAR GENETICS, 2021, 30 (R1) : R129 - R137
  • [3] Effect of APOL1 disease risk variants on APOL1 gene product
    Haque, Shabirul
    Patil, Gauri
    Mishra, Abheepsa
    Lan, Xiqian
    Popik, Waldemar
    Malhotra, Ashwani
    Skorecki, Karl
    Singhal, Pravin C.
    BIOSCIENCE REPORTS, 2017, 37
  • [4] APOL1 and kidney disease
    Pollak, Martin R.
    Genovese, Giulio
    Friedman, David J.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2012, 21 (02): : 179 - 182
  • [5] APOL1 and Kidney Disease: From Genetics to Biology
    Friedman, David J.
    Pollak, Martin R.
    ANNUAL REVIEW OF PHYSIOLOGY, VOL 82, 2020, 82 : 323 - 342
  • [6] Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
    Genovese, Giulio
    Friedman, David J.
    Ross, Michael D.
    Lecordier, Laurence
    Uzureau, Pierrick
    Freedman, Barry I.
    Bowden, Donald W.
    Langefeld, Carl D.
    Oleksyk, Taras K.
    Knob, Andrea L. Uscinski
    Bernhardy, Andrea J.
    Hicks, Pamela J.
    Nelson, George W.
    Vanhollebeke, Benoit
    Winkler, Cheryl A.
    Kopp, Jeffrey B.
    Pays, Etienne
    Pollak, Martin R.
    SCIENCE, 2010, 329 (5993) : 841 - 845
  • [7] APOL1 Variant and Kidney Disease
    Hilliard, Constance B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (12):
  • [8] APOL1 Kidney Risk Variants and Proteomics
    Chen, Teresa K.
    Surapaneni, Aditya L.
    Arking, Dan E.
    Ballantyne, Christie M.
    Boerwinkle, Eric
    Chen, Jingsha
    Coresh, Josef
    Koettgen, Anna
    Susztak, Katalin
    Tin, Adrienne
    Yu, Bing
    Grams, Morgan E.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (05): : 684 - 692
  • [9] APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease
    Parsa, Afshin
    Kao, W. H. Linda
    Xie, Dawei
    Astor, Brad C.
    Li, Man
    Hsu, Chi-yuan
    Feldman, Harold I.
    Parekh, Rulan S.
    Kusek, John W.
    Greene, Tom H.
    Fink, Jeffrey C.
    Anderson, Amanda H.
    Choi, Michael J.
    Wright, Jackson T., Jr.
    Lash, James P.
    Freedman, Barry I.
    Ojo, Akinlolu
    Winkler, Cheryl A.
    Raj, Dominic S.
    Kopp, Jeffrey B.
    He, Jiang
    Jensvold, Nancy G.
    Tao, Kaixiang
    Lipkowitz, Michael S.
    Appel, Lawrence J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (23): : 2183 - 2196
  • [10] A Focus on APOL1 and Kidney Disease
    Nestor, Jordan
    Mohan, Sumit
    KIDNEY INTERNATIONAL REPORTS, 2019, 4 (07): : 901 - 903
12345